Ovarian cancer is the number one cause of mortality among all gynecological malignancies. However, ovarian cancer is also very complicated. Different stages, surgical outcomes, or responses to chemo-therapeutics require different approaches. This article explores different conventional and modern pharmaceutical therapies for ovarian cancer under various circumstances, and attempts to suggest a more optimal therapy according to current research.